Title:
Insulinoma in the dog part 2: a retrospective study of 23 cases (2002-2008)
Author(s):
E. PIETERS, A. VANHAESEBROUCK, S. DAMINET, J.H. SAUNDERS, K. PEREMANS, L. VAN HAM
Abstract:
Twenty-three dogs with insulinoma were included in this retrospective study. These tumors were mostly foundin middle-aged to old dogs, weighing over 25 kg. The most important symptoms were weakness, seizures andcollapse. The mean duration of clinical signs before referral was 5 months. Interestingly, the onset of clinical signswas reported more frequently during the summer months.Paired serum glucose and insulin concentrations were measured in all dogs. Fructosamine concentrations weremeasured in more than one third of the cases, all showing levels lower than normal (258 μmol/l). In 50% of the dogs,abdominal ultrasound detected signs of an insulinoma, but only in one third of the cases nodules were visible.Scintigraphy, with the radiopharmaceutical drug Indium-111 pentetreotide, was performed in 6 dogs, with a detectionrate of 83%. Electrophysiological examination of 3 dogs confirmed the clinical signs of an insulinoma-associatedpolyneuropathy. Histopathological examination of 5 dogs demonstrated the presence of an insulinoma.In one third of the dogs metastases were present at the time of diagnosis. The mean survival time after diagnosiswas 10,3 months. There was no significant difference in survival between the medicinally and surgically treatedgroup. However, it is difficult to make a definitive conclusion, because of the low number of surgically treated dogs.